| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |